Researchers identified no changes in patients’ enzyme levels in a manner that would be indicative of liver damage.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
While all three interventions improved sleep quality, cannabis preparations provided additional improvements in patients’ overall health-related quality of life.
Long-term cannabis treatment reduced patients’ TS symptoms without adversely impacting their cognitive performance or psychological well-being.
Patients who consumed cannabis products “demonstrated sustained and clinically meaningful improvements in depression, anxiety, health-related quality of life, and sleep quality over 24 months.”
Researchers reported “improvements in core behavioral domains” following patients’ use of CBD-dominant extracts.
Respondents frequently acknowledged cannabis to be “just as or more effective” than traditional prescription medications.
Activists now have the option of revising and resubmitting their petition for reconsideration.
Patients who applied THC-dominant topicals reported the greatest physical improvements.